Driskill, Jordan H. Dermawan, Josephine K. Antonescu, Cristina R. Pan, Duojia
Gene fusions are well-known drivers of cancer and are potent targets for molecular therapy. An emerging spectrum of human tumors harbors recurrent and pathognomonic gene fusions that involve the transcriptional coactivator YAP1 (which encodes the protein YAP) or its paralog WWTR1 (which encodes the protein TAZ). YAP and TAZ are frequently activated...
Zhang, Baolu Zhu, Qing Qu, Di Zhao, Mao Du, Juan Zhang, Hengxiang Wang, Hao Jiang, Linhan Yi, Xiuli Guo, Sen
...
Published in
Frontiers in Molecular Biosciences
Introduction Acetyl-CoA synthetase 2 (ACSS2), one of the enzymes that catalyze the conversion of acetate to acetyl-CoA, has been proved to be an oncogene in various cancers. However, the function of ACSS2 is still largely a black box in melanoma. Methods The ACSS2 expression was detected in melanoma cells and melanocytes at both protein and mRNA le...
Kim, Garam Bhattarai, Poshan Yugal Lim, Sung-Chul Lee, Kwang Youl Choi, Hong Seok
Published in
Cellular oncology (Dordrecht)
Nuclear accumulation of YAP/TAZ promotes tumorigenesis in several cancers, including melanoma. Although the mechanisms underlying the nuclear retention of YAP are known, those underlying the retention of TAZ remain unclear. Our study investigates a novel acetylation/deacetylation switch in TAZ, governing its subcellular localization in melanoma tum...
Taylor, Jasmine Dubois, Fatéméh Bergot, Emmanuel Levallet, Guénaëlle
The prognosis for patients with non‑small cell lung cancer (NSCLC), a cancer type which represents 85% of all lung cancers, is poor with a 5‑year survival rate of 19%, mainly because NSCLC is diagnosed at an advanced and metastatic stage. Despite recent therapeutic advancements, ~50% of patients with NSCLC will develop brain metastases (BMs).Either...
Isaac, Roi Bandyopadhyay, Gautam Rohm, Theresa V Kang, Sion Wang, Jinyue Pokhrel, Narayan Sakane, Sadatsugu Zapata, Rizaldy Libster, Avraham M Vinik, Yaron
...
The mechanisms of hepatic stellate cell (HSC) activation and the development of liver fibrosis are not fully understood. Here, we show that deletion of a nuclear seven transmembrane protein, TM7SF3, accelerates HSC activation in liver organoids, primary human HSCs, and in vivo in metabolic-dysfunction-associated steatohepatitis (MASH) mice, leading...
Zhai, Chaojun Wang, Yunfeng Qi, Shenao Yang, Muhan Wu, Shian
Published in
Journal of genetics and genomics = Yi chuan xue bao
Yorkie (Yki) is a key effector of the Hippo pathway that activates the expression of targets by associating with the transcription factor Scalloped (Sd). Various upstream signals, such as cell polarity and mechanical cues, control transcriptional programs by regulating Yki activity. Searching for Yki regulatory factors has far-reaching significance...
Hong, Qiang Fan, Mengmeng Cai, Rui Shi, Wenhui Xie, Fenfen Chen, Yuanhua Li, Cong
Published in
Biochemical and biophysical research communications
The proliferation and apoptosis of ovarian granulosa cells are important for folliculogenesis. As a transcription factor, SRY-box transcription factor 4 (SOX4) has important roles in regulating cellular proliferation and apoptosis. Nonetheless, the regulatory mechanisms of SOX4 on proliferation and apoptosis of granulosa cells remain elusive. There...
Song, Mengyang Wang, He Liu, Caixia Jin, Sijie Liu, Bin Sun, Wei
Published in
Frontiers in Pharmacology
Cardiovascular diseases pose a serious threat to human health. The onset of cardiovascular diseases involves the comprehensive effects of multiple genes and environmental factors, and multiple signaling pathways are involved in regulating the occurrence and development of cardiovascular diseases. The Hippo pathway is a highly conserved signaling pa...
Sun, Yifan Tang, Lanlan Kan, Xianjin Tan, Lei Song, Cuiping Qiu, Xusheng Liao, Ying Nair, Venugopal Ding, Chan Liu, Xiufan
...
Published in
Journal of Virology
The oncolytic Newcastle disease virus (NDV) is being developed for use in cancer treatment; however, its oncolytic mechanism is still not completely understood. The Hippo pathway, which is a tumor suppressor pathway, is frequently dysregulated in tumor tissues due to aberrant yes-associated protein 1 (YAP) activation. In this study, we have demonst...
Liu, Kaijing Wehling, Lilija Wan, Shan Weiler, Sofia M E Tóth, Marcell Ibberson, David Marhenke, Silke Ali, Adnan Lam, Macrina Guo, Te
...
Published in
Cellular and molecular life sciences : CMLS
The Hippo pathway and its transcriptional effectors yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are targets for cancer therapy. It is important to determine if the activation of one factor compensates for the inhibition of the other. Moreover, it is unknown if YAP/TAZ-directed perturbation affects cell-...